BXP.L

Healthcare Drug Manufacturers - Specialty & Generic

Beximco Pharmaceuticals PLC.

£54.00
+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap
24.09B
Avg Volume
42,761
P/E (TTM)
4.50
EPS
£0.12
52W High
£65.00
Div. Yield
0.0%

Valuation

Forward P/E
0.07
P/B Ratio
0.00

Margins

Gross Margin 47.4%
Operating Margin 0.0%
Net Margin 16.0%
EBITDA Margin 24.3%

Growth & Returns

Revenue Growth (YoY)
8.1%
Earnings Growth (YoY)
29.0%
Earnings Growth (QoQ)
29.0%
Return on Equity
14.7%
Return on Assets
9.2%

Liquidity & Leverage

Current Ratio
4.13
Quick Ratio
1.40
Debt / Equity
0.05

About

Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. Beximco Pharmaceuticals PLC. was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

beximcopharma.com